Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Orthotopic hepatocellular carcinoma model with a controlled and reproducible tumorigenicity.

Okubo H, Takei Y, Serizawa N, Enomoto N, Ikejima K, Sato N.

J Gastroenterol Hepatol. 2007 Mar;22(3):423-8.

PMID:
17295777
2.
3.

Establishment of reproducible osteosarcoma rat model using orthotopic implantation technique.

Yu Z, Sun H, Fan Q, Long H, Yang T, Ma B.

Oncol Rep. 2009 May;21(5):1175-80.

PMID:
19360291
4.

[Establishment and biological characteristics of orthotopic transplantation tumor model of hepatocellular carcinoma in mice].

Han KQ, Gu W, Hu X, Zhang YN, Huang XQ, Liu L, Su YH, Ling CQ.

Zhong Xi Yi Jie He Xue Bao. 2004 Sep;2(5):372-4. Chinese.

5.
6.

[Experimental model of hepatic tumor in the rat: description and results of intrahepatic implantation technique].

Giuliante F, Ardito F, Di Mugno M, Belli P, Ponzano C, Palombini G, Nuzzo G.

Ann Ital Chir. 2003 Sep-Oct;74(5):567-71. Italian.

PMID:
15139714
7.

A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation.

Yang R, Rescorla FJ, Reilly CR, Faught PR, Sanghvi NT, Lumeng L, Franklin TD Jr, Grosfeld JL.

J Surg Res. 1992 Mar;52(3):193-8.

PMID:
1538593
8.

Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection?

Thalheimer A, Otto C, Bueter M, Illert B, Gattenlohner S, Gasser M, Fein M, Germer CT, Waaga-Gasser AM.

Eur Surg Res. 2009;42(3):195-200. doi: 10.1159/000205825. Epub 2009 Mar 6.

PMID:
19270457
9.

Generation and modulation of hepatocellular carcinoma circulating cells: a new experimental model.

Scatton O, Chiappini F, Liu XH, Riou P, Marconi A, Debuire B, Azoulay D, Lemoine A.

J Surg Res. 2008 Dec;150(2):183-9. doi: 10.1016/j.jss.2008.03.052. Epub 2008 Apr 28.

PMID:
18708197
10.

Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.

Wang Z, Zhou J, Fan J, Tan CJ, Qiu SJ, Yu Y, Huang XW, Tang ZY.

J Cancer Res Clin Oncol. 2009 May;135(5):715-22. doi: 10.1007/s00432-008-0506-z. Epub 2008 Nov 11.

PMID:
19002496
11.

Splenic metastasis of hepatocellular carcinoma.

Hayashi H, Tanaka S, Shuto T, Tanaka H, Ichikawa T, Yamamoto T, Takemura S, Hirohashi K, Kubo S.

Osaka City Med J. 2006 Dec;52(2):79-82.

PMID:
17330395
12.

AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.

Thompson SM, Callstrom MR, Knudsen B, Anderson JL, Butters KA, Grande JP, Roberts LR, Woodrum DA.

Cardiovasc Intervent Radiol. 2013 Feb;36(1):198-203. doi: 10.1007/s00270-012-0466-1. Epub 2012 Aug 25.

13.

[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].

Tátrai P.

Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7. Hungarian.

PMID:
19068466
14.

A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.

Shen Z, Wong OG, Yao RY, Liang J, Kung HF, Lin MC.

Cancer Lett. 2008 Dec 18;272(2):268-76. doi: 10.1016/j.canlet.2008.03.064. Epub 2008 Aug 21.

PMID:
18722051
15.

Liver transplantation improves survival of rats bearing hepatoma-3924A.

Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL.

J Surg Res. 1996 Sep;65(1):59-62.

PMID:
8895607
16.

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma.

Semela D, Piguet AC, Kolev M, Schmitter K, Hlushchuk R, Djonov V, Stoupis C, Dufour JF.

J Hepatol. 2007 May;46(5):840-8. Epub 2007 Jan 17. Erratum in: J Hepatol. 2008 Apr;48(4):684.

PMID:
17321636
17.

Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.

Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, Schölmerich J, Kiefer P, Bosserhoff AK, Hellerbrand C.

Cancer Sci. 2009 Apr;100(4):646-53. doi: 10.1111/j.1349-7006.2009.01087.x. Epub 2009 Jan 21.

18.

N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.

Akiba J, Ogasawara S, Kawahara A, Nishida N, Sanada S, Moriya F, Kuwano M, Nakashima O, Yano H.

Oncol Rep. 2008 Dec;20(6):1329-35.

PMID:
19020710
19.

Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1.

Hsieh YH, Wu TT, Huang CY, Hsieh YS, Liu JY.

Chin J Physiol. 2007 Feb 28;50(1):9-15. Erratum in: Chin J Physiol. 2007 Apr 30;50(2):98.

PMID:
17593797
20.

Characterization of a new rat model of head and neck squamous cell carcinoma.

Aubry K, Paraf F, Monteil J, Bessede JP, Rigaud M.

In Vivo. 2008 Jul-Aug;22(4):403-8.

Supplemental Content

Support Center